2018 American Transplant Congress
Outcomes after HIV+ Kidney Transplant: A HOPE in Action Study
The HIV Organ Policy Equity (HOPE) Act allows HIV-infected donor (HIV D+) organs to be transplanted into HIV+ recipients (HIV R+) under research protocols. We…2018 American Transplant Congress
Frequency of Whole-Organ in Lieu of Split-Liver Transplantation over the Last Decade: Children Experienced Increased Wait Time and Death
Background: Organ shortage is a barrier in liver transplantation (LT). Split liver transplantation (SLT) increases organ utilization where a donor provides segmental grafts to 2…2018 American Transplant Congress
Outcomes after HIV+ Liver Transplant: A HOPE in Action Study
1JHU, Baltimore; 2Mount Sinai, New York; 3NIH, Bethesda; 4UCSF, San Francisco; 5UMN, Minneapolis.
The HOPE in Action Pilot Trial (NCT02602262) is assessing the safety and feasibility of HIV+ deceased donor (D+) kidney and liver transplantation for HIV+ recipients…2018 American Transplant Congress
Association of Body Mass Index of Kidney Transplant Recipients with Graft Function Post-Transplant
Henry Ford Transplant Institute, Detroit, MI.
Purpose: Obese kidney transplant recipients (KTR) are known to have a significantly higher risk of delayed graft function; however, there is no data on patients…2018 American Transplant Congress
Racial and Socioeconomic Influences on Kidney Transplantation. A 10 Year Retrospective Study
Recanati/Miller Transplantation Institute, The Mount Sinai Hospital, New York, NY.
Introduction: Racial disparities in kidney transplantation are a widely discussed topic. Studies have shown less access to listing and transplantation, and worse graft survival in…2018 American Transplant Congress
Three-Month Pancreas Graft Function Significantly Influences Survival Following Simultaneous Pancreas-Kidney Transplantation in Type 2 Diabetes
A successful simultaneous pancreas-kidney transplantation (SPK) may improve quality of life, reduce the progression of diabetic complications, and possibly prolong patient and kidney allograft survival…2018 American Transplant Congress
Comparison of De Novo Rapamune versus Everolimus Maintenance Immunosuppression; an Interim Analysis
General Surgery, Ohio State University, Columbus, OH.
This is a 1 year interim analysis of the results of a 3 year, single center, randomized, prospective, open-label study comparing the efficacy and tolerability…2018 American Transplant Congress
Outcomes of Renal Transplantation in Pediatric Patients with VACTERL Association
In this single-center retrospective review, we studied transplant outcomes in nine pediatric patients with VACTERL association, making this the largest study of its kind. Of…2018 American Transplant Congress
Long-Term Efficacy and Safety of Everolimus Based Immunosuppression on De Novo Kidney Transplantation with 9 Years Follow-Up
Purpose: Long-term efficacy and safety of everolimus (EVR) based immunosuppression for de novo kidney transplant recipient who were involved in A1202 study was evaluated in…2018 American Transplant Congress
Comprehensive Validation of Different Clinical Prediction Models on Short- and Long-Term Outcome Following Orthotopic Liver Transplantation
Background: Organ shortage remains a major problem in orthotopic liver transplantation (OLT). An optimal utilization of the donor pool with better prediction of outcome is…
- « Previous Page
- 1
- …
- 91
- 92
- 93
- 94
- 95
- …
- 155
- Next Page »